K
Kyiv Regional Oncological Dispensary | Kyiv, Ukraine
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Estrogen
Giredestrant
Darolutamide
Anastrozole
Palbociclib
Niraparib
Prednisone Versus Abiraterone Acetate
Alectinib
Prednisone
Abiraterone Acetate
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 5 total trials
Locations recently updated
This is a Phase III, global, randomized, open-label, multicenter, study evaluating the efficacy and safety of adjuvant giredestrant compared with end...
Enrolling
Early Breast Cancer
Drug: Endocrine Therapy of Physician's Choice
Drug: Abemaciclib
The purpose of the study is to determine if the combination of niraparib with Abiraterone Acetate (AA) plus prednisone compared with AA plus predniso...
Active, not recruiting
Metastatic Castration-sensitive Prostate Cancer
Drug: Niraparib
Drug: Prednisone
Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer (ARANOTE)
The purpose of the study is to assess the efficacy and safety of darolutamide in combination with standard androgen deprivation therapy (ADT) in pati...
Active, not recruiting
Prostatic Neoplasms
Other: Androgen deprivation therapy (ADT)
Drug: Placebo
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems